Inhibition of α-, β-, γ-, and δ-carbonic anhydrases from bacteria and diatoms withN′-aryl-N-hydroxy-ureas
Open Access
- 1 January 2018
- journal article
- research article
- Published by Taylor & Francis in Journal of Enzyme Inhibition and Medicinal Chemistry
- Vol. 33 (1) , 1194-1198
Abstract
The inhibition of α-, β-, γ-, and δ-class carbonic anhydrases (CAs, EC 4.2.1.1) from bacteria (Vibrio cholerae and Porphyromonas gingivalis) and diatoms (Thalassiosira weissflogii) with a panel of N’-aryl-N-hydroxy-ureas is reported. The α-/β-CAs from V. cholerae (VchCAα and VchCAβ) were effectively inhibited by some of these derivatives, with KIs in the range of 97.5 nM – 7.26 µM and 52.5 nM – 1.81 µM, respectively, whereas the γ-class enzyme VchCAγ was less sensitive to inhibition (KIs of 4.75 – 8.87 µM). The β-CA from the pathogenic bacterium Porphyromonas gingivalis (PgiCAβ) was not inhibited by these compounds (KIs > 10 µM) whereas the corresponding γ-class enzyme (PgiCAγ) was effectively inhibited (KIs of 59.8 nM – 6.42 µM). The δ-CA from the diatom Thalassiosira weissflogii (TweCAδ) showed effective inhibition with these derivatives (KIs of 33.3 nM – 8.74 µM). As most of these N-hydroxyureas are also ineffective as inhibitors of the human (h) widespread isoforms hCA I and II (KIs > 10 µM), this class of derivatives may lead to the development of CA inhibitors selective for bacterial/diatom enzymes over their human counterparts and thus to anti-infectives or agents with environmental applications.Keywords
Funding Information
- DSFP
- King Saud University
This publication has 24 references indexed in Scilit:
- The η-class carbonic anhydrases as drug targets for antimalarial agentsExpert Opinion on Therapeutic Targets, 2014
- Inhibition studies of quinazoline-sulfonamide derivatives against the γ-CA (PgiCA) from the pathogenic bacterium,Porphyromonas gingivalisJournal of Enzyme Inhibition and Medicinal Chemistry, 2014
- A Small‐Molecule Drug Conjugate for the Treatment of Carbonic Anhydrase IX Expressing TumorsAngewandte Chemie International Edition, 2014
- Biochemical characterization of the δ-carbonic anhydrase from the marine diatomThalassiosira weissflogii, TweCAJournal of Enzyme Inhibition and Medicinal Chemistry, 2013
- Anticancer carbonic anhydrase inhibitors: a patent review (2008 – 2013)Expert Opinion on Therapeutic Patents, 2013
- Antiobesity carbonic anhydrase inhibitors: a literature and patent reviewExpert Opinion on Therapeutic Patents, 2013
- Diuretics with carbonic anhydrase inhibitory action: a patent and literature review (2005 – 2013)Expert Opinion on Therapeutic Patents, 2013
- Antiglaucoma carbonic anhydrase inhibitors: a patent reviewExpert Opinion on Therapeutic Patents, 2013
- Carbonic anhydrases: from biomedical applications of the inhibitors and activators to biotechnological use for CO2 captureJournal of Enzyme Inhibition and Medicinal Chemistry, 2013
- Carbonic anhydrase inhibitors. Part 35. Synthesis of Schiff bases derived from sulfanilamide and aromatic aldehydes: the first inhibitors with equally high affinity towards cytosolic and membrane-bound isozymesEuropean Journal of Medicinal Chemistry, 1996